ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,283.40
0.11%
Dow Jones
38,571.03
-0.30%
US Dollar vs MXN
17.88485
1.03%
Brent Oil
76.755
-1.77%
Bitcoin
68,699.70
-0.15%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. BioRestorative Therapies Inc (BRTX)

  7. BioRestorative Therapies Inc (BRTX) Noticias

BRTX BioRestorative Therapies Inc

1.31
0.02 (1.55%)
Pre Mercado
Última actualización: 04:37:40
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioRestorative Therapies Inc BRTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.02 1.55% 1.31 04:37:40
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/5/202418:45GLOBEBioRestorative Therapies Announces Receipt of Nasdaq..
24/5/202415:51EDGAR2Form 8-K - Current report
24/5/202415:45EDGAR2Form 8-K - Current report
16/5/202416:17EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/5/202415:10GLOBEBioRestorative Therapies Provides First Quarter 2024..
08/5/202406:30GLOBEBioRestorative Therapies Enhances Preclinical Metabolic..
30/4/202415:15GLOBEBioRestorative Therapies to Report First Quarter 2024..
30/4/202406:30GLOBEBioRestorative Therapies Announces Transformative Commercial..
16/4/202409:25APSBiotech Catches Major Premarket Bid Following FDA Clearance
16/4/202406:45GLOBEBioRestorative Therapies Announces FDA Clearance of Phase 2..
08/4/202406:45GLOBEBioRestorative Therapies Partners with Galen Patient..
03/4/202415:38GLOBEBioRestorative Therapies Announces Filing of Form S-1..
01/4/202406:45GLOBEBioRestorative Therapies Announces Filing of 2023 Annual..
11/3/202415:15GLOBEBioRestorative Therapies to Participate in the 36th Annual..
06/3/202415:34EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202415:43EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202415:40EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:09EDGAR2Form 8-K - Current report
06/2/202407:05GLOBEBioRestorative Therapies Announces Exercise of Warrants and..
05/2/202407:00EDGAR2Form 8-K - Current report
05/2/202406:30GLOBEBioRestorative Therapies Presents Preliminary Clinical Data..
01/2/202415:43EDGAR2Form 8-K - Current report
01/2/202406:30GLOBEBioRestorative Therapies to Present Preliminary BRTX-100..
12/12/202308:15GLOBEBioRestorative Therapies Receives a Notice of Allowance by..
05/12/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/10/202311:10GLOBEBioRestorative Therapies, Inc. to Participate at the ROTH..
18/9/202308:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202308:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202315:22EDGAR2Form 8-K - Current report
14/9/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202308:00GLOBEBioRestorative Therapies Enters into Supply Agreement with..
08/9/202307:30GLOBEBioRestorative Therapies Announces Activation of Northwell..
06/9/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202312:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202316:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202315:04EDGAR2Form DEF 14A - Other definitive proxy statements

Su Consulta Reciente

NASDAQ
BRTX
BioRestorative Therapies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados